How to Tell If a Mole Is Cancerous: A Visual Guide

Most moles are not cancer. The reason dermatologists ask people to pay attention is that skin cancer can be easier to treat when it is found early, and the first clue is often visual change. A spot that is new, looks unlike your other spots, grows, changes color, itches, bleeds, or does not heal should move from casual watching to professional review. That does not mean the spot is definitely cancerous. It means the pattern deserves a trained eye.

DermAI treats mole screening as an escalation workflow. The product can help organize what you see, compare visible features, and create a clean report for a visit. It should not be used to rule out melanoma. A camera view can miss depth, texture, clinical history, and the full-body context a dermatologist uses during an exam.

ABCDE stands for asymmetry, border, color, diameter, and evolving. In practical terms, look for one half that does not match the other, edges that are irregular or blurred, multiple colors or unusual darkening, a size that is larger than a small pencil eraser, or any meaningful change over time. The final letter, evolving, is often the most useful because it focuses on motion rather than one frozen photo.

The checklist has limits. Some dangerous lesions may be small, and some harmless spots may look irregular. Nail, foot, scalp, and hard-to-see locations can also be missed in casual self-checks. If you are unsure whether a spot has changed, take a well-lit photo with a ruler or coin nearby for scale and book an appointment rather than trying to solve the question alone.

DermAI can structure a mole concern into a repeatable scan report: image quality notes, visible feature prompts, urgency language, and a summary that is easier to share with a dermatologist. It can flag uncertainty and recommend review when visible warning signs appear. The most useful result is not a dramatic label; it is a clear next step and a record of what changed.

For high-risk concerns, the safest design choice is conservative escalation. If a mole is bleeding, rapidly changing, painful, darkening unevenly, or unlike your other spots, DermAI should push you toward care instead of offering reassurance. The report can still help by capturing dates, photos, symptoms, and the reason for concern.

Book a dermatologist visit promptly for a new or changing mole, a spot that is different from your other spots, itching, bleeding, crusting, non-healing skin, or a lesion on an area you cannot monitor well. Seek urgent care if there is severe pain, spreading infection signs, fever, or a wound that looks acutely unsafe. For routine body checks, your risk profile matters: personal or family history, many moles, prior burns, immune suppression, and intense UV exposure all change the threshold for care.

A home scan can be a starting point, not the endpoint. If your concern stays in your mind after reading a result, that concern itself is a good reason to ask a clinician. The best outcome is not proving the app right; it is getting the right level of care quickly.